Cargando…

The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms

Parmotremaperlatum is traditionally used in different areas of Pakistan to treat gastrointestinal, respiratory, and vascular diseases. This study evaluates the underlying mechanisms for traditional uses of P. perlatum in diarrhea, asthma, and hypertension. In vitro pharmacological studies were condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Musaddique, Bakhsh, Hazoor, Syed, Shahzada Khurram, Ullah, Malik Saad, Alqahtani, Ali M., Alqahtani, Taha, Aldahish, Afaf A., Emran, Talha Bin, Rehman, Kashif Ur, Janbaz, Khalid Hussain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588472/
https://www.ncbi.nlm.nih.gov/pubmed/34770756
http://dx.doi.org/10.3390/molecules26216348
_version_ 1784598468992434176
author Hussain, Musaddique
Bakhsh, Hazoor
Syed, Shahzada Khurram
Ullah, Malik Saad
Alqahtani, Ali M.
Alqahtani, Taha
Aldahish, Afaf A.
Emran, Talha Bin
Rehman, Kashif Ur
Janbaz, Khalid Hussain
author_facet Hussain, Musaddique
Bakhsh, Hazoor
Syed, Shahzada Khurram
Ullah, Malik Saad
Alqahtani, Ali M.
Alqahtani, Taha
Aldahish, Afaf A.
Emran, Talha Bin
Rehman, Kashif Ur
Janbaz, Khalid Hussain
author_sort Hussain, Musaddique
collection PubMed
description Parmotremaperlatum is traditionally used in different areas of Pakistan to treat gastrointestinal, respiratory, and vascular diseases. This study evaluates the underlying mechanisms for traditional uses of P. perlatum in diarrhea, asthma, and hypertension. In vitro pharmacological studies were conducted using isolated jejunum, trachea, and aortic preparations, while the cytotoxic study was conducted in mice. Crude extract of P. perlatum(Pp.Cr), comprising appreciable quantities of alkaloids and flavonoids, relaxed spontaneously contracting jejunum preparation, K(+) (80 mM)-induced, and carbachol (1 µM)-induced jejunum contractions in a concentration-dependent manner similar to dicyclomine and dantrolene. Pp.Cr showed a rightward parallel shift of concentration-response curves (CRCs) of Cch after a non-parallel shift similarto dicyclomine and shifted CRCs of Ca(+2) to rightward much likeverapamil and dantrolene, demonstrating the coexistence of antimuscarinic and Ca(+2) antagonistic mechanism. Furthermore, Pp.Cr, dicyclomine, and dantrolene relaxed K(+) (80 mM)-induced and Cch (1 µM)-induced tracheal contractions and shifted rightward CRCs of Cch similar to dicyclomine, signifying the dual blockade. Additionally, Pp.Cr also relaxed the K(+) (80 mM)-induced and phenylephrine (1 µM)-induced aortic contraction, similarly to verapamil and dantrolene, suggesting Ca(+2) channel antagonism. Here, we explored for the first time thespasmolytic and bronchodilator effects of Pp.Crand whether they maybe due to the dual blockade of Ca(+2) channels and muscarinic receptors, while the vasodilator effect might be owing to Ca(+2) antagonism. Our results provide the pharmacological evidence that P. perlatum could be a new potential therapeutic option to treat gastrointestinal, respiratory, and vascular diseases. Hence, there is a need for further research to explore bioactive constituent of P. perlatum as well as further investigation by suitable experimental models are required to further confirm the importance and usefulness of P. perlatum in diarrhea, asthma, and hypertension treatment.
format Online
Article
Text
id pubmed-8588472
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85884722021-11-13 The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms Hussain, Musaddique Bakhsh, Hazoor Syed, Shahzada Khurram Ullah, Malik Saad Alqahtani, Ali M. Alqahtani, Taha Aldahish, Afaf A. Emran, Talha Bin Rehman, Kashif Ur Janbaz, Khalid Hussain Molecules Article Parmotremaperlatum is traditionally used in different areas of Pakistan to treat gastrointestinal, respiratory, and vascular diseases. This study evaluates the underlying mechanisms for traditional uses of P. perlatum in diarrhea, asthma, and hypertension. In vitro pharmacological studies were conducted using isolated jejunum, trachea, and aortic preparations, while the cytotoxic study was conducted in mice. Crude extract of P. perlatum(Pp.Cr), comprising appreciable quantities of alkaloids and flavonoids, relaxed spontaneously contracting jejunum preparation, K(+) (80 mM)-induced, and carbachol (1 µM)-induced jejunum contractions in a concentration-dependent manner similar to dicyclomine and dantrolene. Pp.Cr showed a rightward parallel shift of concentration-response curves (CRCs) of Cch after a non-parallel shift similarto dicyclomine and shifted CRCs of Ca(+2) to rightward much likeverapamil and dantrolene, demonstrating the coexistence of antimuscarinic and Ca(+2) antagonistic mechanism. Furthermore, Pp.Cr, dicyclomine, and dantrolene relaxed K(+) (80 mM)-induced and Cch (1 µM)-induced tracheal contractions and shifted rightward CRCs of Cch similar to dicyclomine, signifying the dual blockade. Additionally, Pp.Cr also relaxed the K(+) (80 mM)-induced and phenylephrine (1 µM)-induced aortic contraction, similarly to verapamil and dantrolene, suggesting Ca(+2) channel antagonism. Here, we explored for the first time thespasmolytic and bronchodilator effects of Pp.Crand whether they maybe due to the dual blockade of Ca(+2) channels and muscarinic receptors, while the vasodilator effect might be owing to Ca(+2) antagonism. Our results provide the pharmacological evidence that P. perlatum could be a new potential therapeutic option to treat gastrointestinal, respiratory, and vascular diseases. Hence, there is a need for further research to explore bioactive constituent of P. perlatum as well as further investigation by suitable experimental models are required to further confirm the importance and usefulness of P. perlatum in diarrhea, asthma, and hypertension treatment. MDPI 2021-10-20 /pmc/articles/PMC8588472/ /pubmed/34770756 http://dx.doi.org/10.3390/molecules26216348 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hussain, Musaddique
Bakhsh, Hazoor
Syed, Shahzada Khurram
Ullah, Malik Saad
Alqahtani, Ali M.
Alqahtani, Taha
Aldahish, Afaf A.
Emran, Talha Bin
Rehman, Kashif Ur
Janbaz, Khalid Hussain
The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title_full The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title_fullStr The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title_full_unstemmed The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title_short The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms
title_sort spasmolytic, bronchodilator, and vasodilator activities of parmotrema perlatum are explained by anti-muscarinic and calcium antagonistic mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588472/
https://www.ncbi.nlm.nih.gov/pubmed/34770756
http://dx.doi.org/10.3390/molecules26216348
work_keys_str_mv AT hussainmusaddique thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT bakhshhazoor thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT syedshahzadakhurram thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT ullahmaliksaad thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT alqahtanialim thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT alqahtanitaha thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT aldahishafafa thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT emrantalhabin thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT rehmankashifur thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT janbazkhalidhussain thespasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT hussainmusaddique spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT bakhshhazoor spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT syedshahzadakhurram spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT ullahmaliksaad spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT alqahtanialim spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT alqahtanitaha spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT aldahishafafa spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT emrantalhabin spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT rehmankashifur spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms
AT janbazkhalidhussain spasmolyticbronchodilatorandvasodilatoractivitiesofparmotremaperlatumareexplainedbyantimuscarinicandcalciumantagonisticmechanisms